NIH and Pharma Partner to Boost Cancer Immunotherapy.
The National Institutes of Health has joined 11 biopharmaceutical companies in establishing a Partnership for Accelerating Cancer Therapies (PACT), a 5-year, $215 million research collaboration to identify biomarkers that will help personalize treatments that harness the immune system to attack cancer.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | General Medicine | Immunotherapy | National Institutes of Health (NIH) | Partnerships | Pharmaceuticals